Dundas Partners LLP Abbott Laboratories Transaction History

Dundas Partners LLP

$1.38 Billion
Q3 2024

A detailed history of Dundas Partners LLP transactions in Abbott Laboratories stock. As of the latest transaction made, Dundas Partners LLP holds 345,049 shares of ABT stock, worth $39.4 Million. This represents 2.85% of its overall portfolio holdings.

Number of Shares

345,049

Previous 330,227 4.49%

Holding current value

$39.4 Million

Previous $34.3 Million 14.65%

% of portfolio

2.85%

Previous 2.66%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$100.07 - $118.13 $1.48 Million - $1.75 Million	14,822 Added 4.49%	345,049 $39.3 Million
Q2 2024 Aug 14, 2024	BUY	$100.73 - $112.44 $694,734 - $775,498	6,897 Added 2.13%	330,227 $34.3 Million
Q3 2023 Nov 14, 2023	BUY	$95.53 - $114.62 $3.41 Million - $4.1 Million	35,740 Added 12.43%	323,330 $31.3 Million
Q1 2023 May 12, 2023	SELL	$96.86 - $114.01 $130,373 - $153,457	-1,346 Reduced 0.47%	287,590 $29.1 Million
Q4 2022 Feb 08, 2023	BUY	$95.06 - $111.52 $446,782 - $524,144	4,700 Added 1.65%	288,936 $31.7 Million
Q1 2022 May 13, 2022	BUY	$114.02 - $139.04 $6.8 Million - $8.29 Million	59,653 Added 26.56%	284,236 $33.6 Million
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $1.85 Million - $2.27 Million	16,036 Added 7.69%	224,583 $28.4 Million
Q2 2019 Aug 01, 2019	BUY	$72.88 - $85.0 $200,711 - $234,090	2,754 Added 1.34%	208,547 $17.5 Million
Q3 2018 Nov 13, 2018	BUY	$60.81 - $73.36 $3.19 Million - $3.85 Million	52,429 Added 34.19%	205,793 $19.6 Million
Q2 2018 Jul 26, 2018	SELL	$57.57 - $63.54 $1.68 Million - $1.85 Million	-29,131 Reduced 15.96%	153,364 $9.37 Million
Q1 2018 Jun 06, 2018	BUY	$56.27 - $63.62 $10.3 Million - $11.6 Million	182,495 New	182,495 $10.4 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dundas Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Dundas Partners LLP with notifications on news.

Account

Dundas Partners LLP Abbott Laboratories Transaction History